Mr Scott Warren > Dechert LLP > Silicon Valley, United States > Lawyer Profile
Dechert LLP Offices
3000 El Camino Real
Five Palo Alto Square, Suite 650
Palo Alto, CA 94306-2112
CALIFORNIA
United States
- Firm Profile
- Go to...
Mr Scott Warren
Work Department
Intellectual Property
Position
Partner
Career
Scott A. Warren advises clients in the pharmaceutical, chemical, nutraceutical and medical device industries on intellectual property matters, particularly patent matters. His extensive experience includes handling litigation, opinion (invalidity, clearance and due diligence), counseling, patent prosecution, and interference matters before the U.S. Patent and Trademark Office.
Mr. Warren’s scientific background makes him uniquely qualified to advise clients in the life sciences sector. Before launching his legal career, he studied molecular biology as an undergraduate at Princeton University and pursued doctoral studies in cancer biology at Stanford University.
Mr. Warren has served as a faculty member in the Biotechnology section of the Practicing Law Institute’s Advanced Patent Prosecution Workshop. His teaching activities have also included serving as an adjunct professor at the Franklin Pierce Law Center for three years.
Prior to joining Dechert, Mr. Warren served as a partner in the litigation department of another international law firm.
Education
- Princeton University, A.B., Molecular Biology, 1986
- Columbia Law School, J.D., 1997
Top Tier Firm Rankings
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate finance
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Finance > Structured finance: securitization
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > E-discovery
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Tax > International tax
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: transactional
- Dispute resolution > International arbitration
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- International trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Finance > Capital markets: high-yield debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > Financial services litigation